content: <?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
    <headerData>
      <submissionType>144</submissionType>
      <filerInfo>
        <filer>
          <filerCredentials>
            <!-- Field: Pseudo-Tag; ID: Name; Data: ORBIMED CAPITAL LLC -->
            <cik>0001157524</cik>
            <ccc>XXXXXXXX</ccc>
          </filerCredentials>
        </filer>
        <liveTestFlag>LIVE</liveTestFlag>
  
  
  
      </filerInfo>
    </headerData>
    <formData>
      <issuerInfo>
        <issuerCik>0001671858</issuerCik>
        <issuerName>ARS Pharmaceuticals, Inc.</issuerName>
        <secFileNumber>001-39756</secFileNumber>
        <issuerAddress>
          <com:street1>11682 EL CAMINO REAL, SUITE 120</com:street1>
          <com:city>SAN DIEGO</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>92130</com:zipCode>
        </issuerAddress>
        <issuerContactPhone>8587719307</issuerContactPhone>
        <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>OrbiMed Partners Master Fund Limited</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
        <relationshipsToIssuer>
          <relationshipToIssuer>Shareholder</relationshipToIssuer>
        </relationshipsToIssuer>
      </issuerInfo>
      <securitiesInformation>
        <securitiesClassTitle>Common Stock</securitiesClassTitle>
        <brokerOrMarketmakerDetails>
          <name>Themis Trading LLC</name>
          <address>
            <com:street1>10 Town Square</com:street1>
            <com:street2>Suite 100</com:street2>
            <com:city>Chatham</com:city>
            <com:stateOrCountry>NJ</com:stateOrCountry>
            <com:zipCode>07928</com:zipCode>
          </address>
        </brokerOrMarketmakerDetails>
        <noOfUnitsSold>952377</noOfUnitsSold>
        <aggregateMarketValue>14180894.00</aggregateMarketValue>
        <noOfUnitsOutstanding>96941609</noOfUnitsOutstanding>
        <approxSaleDate>08/21/2024</approxSaleDate>
        <securitiesExchangeName>Nasdaq</securitiesExchangeName>
      </securitiesInformation>
      <securitiesToBeSold>
        <securitiesClassTitle>Common Stock</securitiesClassTitle>
        <acquiredDate>12/08/2020</acquiredDate>
        <natureOfAcquisitionTransaction>IPO</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>952377</amountOfSecuritiesAcquired>
        <paymentDate>12/08/2020</paymentDate>
        <natureOfPayment>Cash</natureOfPayment>
      </securitiesToBeSold>
      <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
      <remarks>OrbiMed Capital LLC is the investment advisor of OrbiMed Partners Master Fund Limited.</remarks>
      <noticeSignature>
        <noticeDate>08/21/2024</noticeDate>
        <signature>/s/ Douglas Coon, Chief Compliance Officer, OrbiMed Capital LLC, investment advisor of OrbiMed Partners Master Fund Limited</signature>
      </noticeSignature>
    </formData>
  </edgarSubmission>
metadata_documents: [{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 3070}]
text: 144
  0001157524
  XXXXXXXX
  LIVE
  0001671858
  ARS Pharmaceuticals, Inc.
  001-39756
  11682 EL CAMINO REAL, SUITE 120
  SAN DIEGO
  CA
  92130
  8587719307
  OrbiMed Partners Master Fund Limited
  Shareholder
  Common Stock
  Themis Trading LLC
  10 Town Square
  Suite 100
  Chatham
  NJ
  07928
  952377
  14180894.00
  96941609
  08/21/2024
  Nasdaq
  Common Stock
  12/08/2020
  IPO
  Issuer
  N
  952377
  12/08/2020
  Cash
  Y
  OrbiMed Capital LLC is the investment advisor of OrbiMed Partners Master Fund Limited.
  08/21/2024
  /s/ Douglas Coon, Chief Compliance Officer, OrbiMed Capital LLC, investment advisor of OrbiMed Partners Master Fund Limited